-+ 0.00%
-+ 0.00%
-+ 0.00%

Did DCF Value Gap Just Shift Ackermans & Van Haaren's (ENXTBR:ACKB) Investment Narrative?

Simply Wall St·10/18/2026 11:24:39
Listen to the news
  • Ackermans & Van Haaren has recently been highlighted for a 96.5% total return over the past three years and for a DCF analysis that places its intrinsic value substantially above the current share price, with a net cash position that allows room for further investments.
  • The combination of strong historical returns, a DCF value exceeding the market price, and surplus cash for new projects is drawing investor attention to whether future cash flows can support the current enthusiasm around Ackermans & Van Haaren.
  • We will examine how Ackermans & Van Haaren's investment narrative relates to its DCF upside and sizeable net cash position.

Compare Ackermans & Van Haaren's DCF gap and cash-rich position with a curated set of other potential value ideas by scanning the 191 high quality undervalued stocks that are poised for a possible rerating.

Ackermans & Van Haaren Investment Narrative Recap

An investor in Ackermans & Van Haaren needs to trust that its mix of marine engineering, banking, real estate, energy and growth capital can keep turning current cash flows into disciplined projects. The recent 96.5% three year total return and DCF gap sharpen the focus on execution in DEME, Delen, Bank Van Breda and newer holdings as the near term swing factor.

The main short term catalyst is how effectively that €362 million net cash and solid free cash flow get redeployed into projects that keep earnings quality high without stretching the balance sheet. Concentration in a few key subsidiaries and integration risk in newer investments remain the biggest operational watchpoints.

Without fresh company announcements tied directly to this valuation debate, the most relevant reference point is still the reported performance of DEME, Delen Private Bank and Bank Van Breda. These engines drove record turnover and strong inflows, which helps explain why a cash rich holding group like Ackermans & Van Haaren screens well on a DCF model.

For catalysts, the key question is how that earlier operational strength in banking and marine activities interacts with the current discount to both analyst targets and estimated intrinsic value. Execution on external growth projects such as V. Group and Confo Therapeutics now matters more, because any stumble would quickly challenge the cash flow assumptions behind the recent enthusiasm.

Ackermans & Van Haaren's current analyst storyline points to revenues of €6.2b and earnings of €657.2m by 2029, built on 1.5% yearly revenue growth and an earnings decline of about €1.7m from €658.9m today.

Uncover why Ackermans & Van Haaren's fair value indicates a 19% potential upside to its current price, which could narrow quickly if sentiment shifts.

ENXTBR:ACKB 1-Year Stock Price Chart
ENXTBR:ACKB 1-Year Stock Price Chart

Exploring Other Perspectives

Three fair value estimates from the Simply Wall St Community span roughly €311.86 to €445.81, so private investors are clearly not aligned on what Ackermans & Van Haaren is worth. When you set that against concentration risks in DEME, Delen and Bank Van Breda, you see why exploring several competing viewpoints really matters.

Explore 2 other Ackermans & Van Haaren fair value estimates, including one that suggests it could be worth just €311.86.

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

  • A great starting point for your Ackermans & Van Haaren research is our analysis highlighting 3 key rewards that could impact your investment decision.
  • See our latest analysis for Ackermans & Van Haaren. The report includes a comprehensive fundamental analysis summarized in a single visual, the Snowflake, making it easy to evaluate Ackermans & Van Haaren's overall financial health at a glance.

Looking For More Investment Ideas Beyond Ackermans & Van Haaren?

If you want to broaden your watchlist beyond Ackermans & Van Haaren, the Simply Wall St screener can help you quickly sort through other listed businesses that match your style, whether you care most about value, stability, income, or a mix of all three.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.